Skip to main navigation Skip to search Skip to main content

PCSK9 inhibitors and the risk of vitiligo: a Mendelian randomization study

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalJournal of Investigative Dermatology
StatePublished - 2025.04.1

Cite this